Hemolysate-mediated renal vasoconstriction and hypersensitization.
The present studies measured vessel diameter, before and after addition of hemolysate, in isolated afferent arterioles (AA) and efferent arterioles (EA) obtained from the rat kidney. Human red blood cells (RBC) were hemolyzed in distilled water and membranes were discarded after centrifugation. Hemolysate added to the bath solution caused vigorous AA and EA contraction and, after washout, hypersensitized the AA and EA to doses of angiotensin II (AII) which would normally only elicit 50% contraction (EC50). Neither the contraction nor the hypersensitization were mimicked by pure human hemoglobin. The vasoconstrictive responses in the AA and EA were accompanied by increased cytosolic-free calcium concentration. Further purification (desalting) of the hemolysate to remove substance of < or = 1000 Da (which include ATP) did not eliminate the vasoconstrictive component from the hemolysate. Finally, cultured rat aortic vascular smooth muscle cells also demonstrated a rapid increase in (Ca2+i) when exposed to hemolysate. This increase in (Ca2+i) was, in part, dependent on Ca2+ influx since it could be attenuated with diltiazem (10(-5) M). In conclusion, hemolysate contains a factor which induces contractions of the isolated rat kidney AA and EA and rapid elevations in (Ca2+i). This factor, from hemolyzed RBC, is not hemoglobin itself.
Division of Renal Diseases and Hypertension, University of Colorado Medical School, Denver 80262, USA. Tom.Burke@uchsc.edu
T J
TJ
Burke
S
S
Falk
J D
JD
Conger
N F
NF
Voelkel
D000818:Animals; D001011:Aorta / Q000187:drug effects; D001160:Arterioles / Q000187:drug effects / Q000502:physiology*; D001685:Biological Factors / Q000494:pharmacology*; D002118:Calcium / Q000378:metabolism; D004110:Diltiazem / Q000378:metabolism; D004912:Erythrocytes / Q000737:chemistry*; D006461:Hemolysis; D066298:In Vitro Techniques; D007668:Kidney / Q000098:blood supply*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D051381:Rats; D014661:Vasoconstriction / Q000187:drug effects*
D001685:Biological Factors; D004110:Diltiazem; D002118:Calcium